Product image of Linadax Once Weekly «μία Φορά Την Εβδομάδα» (Alendronate Sodium Trihydrate) supplied by GNH India

Linadax Once Weekly «μία Φορά Την Εβδομάδα»

Active Ingredient:
Alendronate Sodium Trihydrate
Origin:
EU

Linadax Once Weekly «μία Φορά Την Εβδομάδα» (Alendronate Sodium Trihydrate)

Alendronate Sodium Trihydrate, the active ingredient in Linadax Once Weekly, is a bisphosphonate presented as a tablet for oral use. It is indicated for the treatment of osteoporosis in postmenopausal women, men, and patients receiving long‑term glucocorticoids. The drug works by inhibiting bone resorption and is supplied under a prescription‑only status.

GNH India supplies Linadax Once Weekly as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Heremco

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linadax Once Weekly is a bisphosphonate used to manage conditions characterized by increased bone loss.

  • Postmenopausal osteoporosis: reduces fracture risk by increasing bone mineral density.
  • Male osteoporosis: improves skeletal strength and lowers incidence of vertebral and non‑vertebral fractures.
  • Glucocorticoid‑induced osteoporosis: counteracts steroid‑related bone loss and helps maintain bone mass.

How It Works

  • Alendronate sodium trihydrate binds selectively to hydroxyapatite crystals at sites of active bone remodeling. When osteoclasts resorb bone, the drug is released and inhibits farnesyl pyrophosphate synthase in the mevalonate pathway, preventing prenylation of essential signaling proteins. This suppresses osteoclast activity, leading to reduced bone resorption and a net gain in bone density.

Side Effects

Common Side Effects

  • Abdominal pain: mild discomfort in the upper abdomen.
  • Dyspepsia: indigestion or heartburn.
  • Nausea: feeling of queasiness.
  • Constipation: infrequent, hard stools.
  • Musculoskeletal pain: aches in muscles or joints.
  • Headache: mild to moderate tension.

Serious or Rare Side Effects

  • Osteonecrosis of the jaw: exposed bone in the oral cavity.
  • Atypical femur fracture: unusual break in the thigh bone.
  • Severe esophagitis: inflammation causing pain or difficulty swallowing.
  • Hypersensitivity reactions: rash, swelling, or anaphylaxis.
  • Acute‑phase reaction: fever, myalgia, or flu‑like symptoms.
  • Renal impairment: reduced kidney function, especially with high doses.

Precautions & Warnings

Before starting therapy, consider the following precautions:

  • Renal function assessment: ensure adequate kidney function before prescribing.
  • Calcium and vitamin D intake: maintain sufficient dietary levels to support bone health.
  • Empty‑stomach administration: take the tablet with a full glass of water at least 30 minutes before food or other meds.
  • Upright posture: remain upright for at least 30 minutes after dosing to reduce esophageal irritation.
  • Concomitant medications: review other drugs that may affect absorption or increase gastrointestinal risk.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Alendronate may interact with several agents that affect its absorption or safety profile.

Major Interactions (Avoid)

  • Calcium supplements taken simultaneously: can bind the drug and reduce its effectiveness.
  • Antacids containing aluminum, magnesium, or calcium: interfere with absorption if taken within 30 minutes of the dose.
  • Other bisphosphonates: concurrent use offers no added benefit and increases risk of adverse effects.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of gastrointestinal irritation.
  • Warfarin: alendronate can potentiate anticoagulant effect, requiring INR monitoring.
  • Diuretics (especially thiazides): may affect calcium balance and renal handling.

Frequently Asked Questions

Linadax Once Weekly contains alendronate sodium trihydrate and is prescribed to treat osteoporosis in postmenopausal women, men, and patients receiving long‑term glucocorticoid therapy. It helps increase bone mineral density and reduces the risk of vertebral and non‑vertebral fractures.

Alendronate binds to hydroxyapatite at sites of active bone remodeling. When osteoclasts resorb bone, the drug is released and blocks farnesyl pyrophosphate synthase in the mevalonate pathway, preventing essential protein prenylation. This suppresses osteoclast activity, decreasing bone resorption and allowing bone formation to predominate.

The specific dose of Linadax Once Weekly is determined by the prescribing clinician based on the patient’s condition, renal function, and other clinical factors. It is typically administered as a single oral tablet once per week, but the exact strength and schedule must be confirmed by the prescriber.

Safety of alendronate in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Linadax delivers alendronate once weekly, which offers comparable efficacy to daily or monthly regimens of other bisphosphonates while improving adherence. Its weekly dosing reduces gastrointestinal exposure compared with daily tablets, and it shares a similar safety profile, including risks of esophagitis, osteonecrosis of the jaw, and atypical femur fractures.

Store Linadax Once Weekly at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat, and direct sunlight, and ensure they are out of reach of children.

Take the tablet with a full glass of plain water on an empty stomach, at least 30 minutes before any food, beverage, or other medication. Remain upright for at least 30 minutes after swallowing to minimize the risk of esophageal irritation.

Serious adverse events include osteonecrosis of the jaw, atypical femur fractures, severe esophagitis, hypersensitivity reactions such as anaphylaxis, and acute‑phase reactions with fever and muscle pain. Patients should report any persistent jaw pain, unusual thigh pain, or swallowing difficulties to their healthcare provider promptly.

Linadax is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), active esophageal disorders that delay emptying, known hypersensitivity to alendronate or other bisphosphonates, and those unable to remain upright for 30 minutes after dosing. Clinicians should evaluate these factors before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Alendronate Sodium Trihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT